ClinicalTrials.gg

Program

Genistein-based BIO 300

Also written as “BIO 300 Oral Suspension”, “BIO 300 Oral Powder” and “BIO 300 Capsules”.

Its studies are mostly in Post-Acute COVID-19 Syndrome · Carcinoma, Non-Small-Cell Lung · Radiation Injuries, led by Humanetics.

Furthest: phase 2, since Jul 9, 20155 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Humanetics51 open or runningphase 2since Jul 9, 2015Jul 19, 2007none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 19, 2007First study: phase 1 study in Acute Radiation SyndromeFirst studyNCT00504335 · 24 enrolled
  2. Jul 9, 2015Phase 2 study in Carcinoma, Non-Small-Cell LungNCT02567799 · 21 enrolled · United States
  3. Jul 17, 2020Phase 2 study in COVID-19NCT04482595 · 50 enrolled · United States
  4. Nov 19, 2020Phase 1 study in Acute Radiation SyndromeNCT04650555 · 34 enrolled · United States
  5. Dec 11, 2024Phase 1 study in Acute Radiation SyndromeNCT06741345 · 56 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06741345Acute Radiation Syndrome · United States1CompletedAug 15, 202556
NCT04650555Acute Radiation Syndrome · United States1CompletedJul 6, 202134
NCT04482595COVID-19 · United States2Active, not recruitingJul 31, 202450
NCT02567799Carcinoma, Non-Small-Cell Lung · United States2CompletedApr 201921
NCT00504335Acute Radiation Syndrome1CompletedSep 200724

How it is read

Names in the registry

  • “BIO 300 Oral Suspension”, 3 entries
  • “BIO 300 Oral Powder”, 1 entry
  • “BIO 300 Capsules”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.